iPRI signs MOU with Ukraine's RE Kavetsky Institute of Experimental and Clinical Oncology

iPRI Signs MOU with RE Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, National Academy of Science of Ukraine

Kyiv, 26 January 2017 — Today, the International Prevention Research Institute, represented by its President, Professor Peter Boyle, concluded discussions and signed an important Memorandum of Understanding with the RE Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology of the National Academy of Science of Ukraine, represented by Academician Vasyl F. Chekhun, Director of the Institute.

Professor Peter Boyle of iPRI after signing MOU with Academician Vasyl F. Chekhun of the RE Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology of the National Academy of Science of Ukraine

The participants in this Memorandum of Understanding, the International Prevention Research Institute, based in Lyon, France and RE Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, situated in Kyiv, Ukraine, share a long-standing commitment to increase capacity in Cancer Prevention. Together, they continue to strive to reduce the burden of cancer both in Ukraine and particularly in surrounding countries.

The International Prevention Research Institute and the RE Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology will work together to develop training opportunities and to implement multiple Cancer Prevention, and Cancer Control, activities in Ukraine. Both parties will work with other Cancer Institutes world-wide to examine the effectiveness of treatments in the general population of cancer patients.

The Ukrainian (Kyiv-based) Research Institute of Experimental and Clinical Oncology was established under the Ministry of Health of the Ukrainian SSR on July 1960. The founder and first director of the Institute was Rostislav E.Kavetsky, Member of the Academy of Sciences of the Ukrainian SSR. Today, the Institute is a strong academic center with considerable material and human resources and more than 50 years of experience in the field of experimental and clinical oncology.

Achievements of the Institute are widely recognized. Research fellows of the Institute have been awarded 18 State Prizes in Science and Technology, 19 laureates of personal prizes of eminent scientists of the NAS of Ukraine, 8 titles of Honoured Workers of Ukraine, and 1 the title of Honoured Doctor of Ukraine.

The Institute has a wide and varied portfolio of research interests. These include study of the Environment and Cancer looking at the effects of potentially carcinogenic environmental factors (chemical carcinogens, ionizing and non-ionizing radiation) on the molecular and cellular processes of carcinogenesis and development of the agents that can modify them. There are also substantial programmes in Translational Medicine looking at innovations in diagnosis and treatment and in Personalised Medicine.

Sorry, comments are closed for this post.

Mission

Founded in 2009 with the broad goal of contributing to the improvement of health in populations worldwide, the International Prevention Research Institute (iPRI) aims to increase prospects for prevention through training, education, prevention research and research into causes worldwide with a focus on low and lower-middle income countries.

iPRI strives to answer three critical questions:

  • Is it healthy?
  • Is it safe?
  • Is it beneficial?

Contact iPRI

An iPRI staff member will reply promptly